A Non-inferiority Phase 2 Study to Evaluate the Safety and Efficacy of PEG-rhGH in the Treatment of AGHD

Clinical trial NCT03104010 · UNKNOWN

Trial details

NCT number: NCT03104010
Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Adult Growth Hormone Deficiency

Start date: 2017-04-01
Primary completion: 2022-02-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.